Reuters logo
in 4 months
BRIEF-DBP: MoU regarding possible licensing agreement on development of Temodex
April 5, 2017 / 11:52 AM / in 4 months

BRIEF-DBP: MoU regarding possible licensing agreement on development of Temodex

1 Min Read

April 5 (Reuters) - Double Bond Pharmaceutical International AB (publ):

* Signed a "Memorandum of Understanding" with international partner regarding a possible licensing agreement on development of Temodex

* Hopes to enter into a license agreement for Temodex with this partner at latest during Q3 2017

Source text: bit.ly/2oCrO1S

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below